首页> 外文期刊>Clinical, Cosmetic and Investigational Dermatology >Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
【24h】

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy

机译:SCD163与MCD163之间的关系及其在麻风病检测和键入中的含义

获取原文
           

摘要

Background: Leprosy is a chronic contagious disease caused by Mycobacterium lepraea . CD163 is a monocyte trans-membrane glycoprotein receptor (mCD163) that sheds from the cell surface and circulates as a soluble (serum) form (sCD163). Changes in the mCD163 and sCD163 levels could mirror the categorization of inflammatory procedure, demonstrating a possible use of CD163 as a diagnostic indicator of inflammation. Objective: To investigate the possible role of CD163 (sCD163 and mCD163) in leprosy pathogenesis and to assess whether CD163 is a helpful inflammatory marker of leprosy development and typing. Patients?and?Methods: This case control study included 70 leprosy patients and 30 healthy controls. Leprosy patients were classified according to the Madrid criteria (1953) into: tuberculoid leprosy (TT), border-line leprosy (BL), and lepromatous leprosy (LL). For all participants, complete blood count (CBC), serum CD163 using ELISA and monocytes positive?for CD163 using flow?cytometry were done. Results: Leprosy patients had significantly low WBCs and platelet counts (p 0.001) and had significantly higher sCD163 (p=0.025) and mCD163 (p=0.042) that were highest in LL followed by BL, then TT patients (p 0.001). There was a significant positive correlation between mCD163 and sCD163 levels in leprosy patients (r=0.896, p 0.001). ROC analysis revealed a significant role of serum sCD163 and of mCD163 positive monocytes in the detection (p 0.001) and typing of leprosy (p=0.002 and p 0.001, respectively). Conclusion: Both sCD163 and mCD163 positive monocytes may have an active role in leprosy pathogenesis. They could be potential biomarkers for leprosy detection and typing.
机译:背景:麻风病是一种由麻痹菌引起的慢性传染病。 CD163是单核细胞跨膜糖蛋白受体(MCD163),其从细胞表面脱落并作为可溶性(血清)形式(SCD163)循环。 MCD163和SCD163水平的变化可能会镜像炎症过程的分类,证明可能使用CD163作为炎症的诊断指标。目的:探讨CD163(SCD163和MCD163)在麻风病发病机制中的可能作用,并评估CD163是否是麻风发育和打字的有用炎症标志物。患者?和?方法:这种情况:这种情况控制研究包括70名麻风病患者和30名健康对照。麻风病患者根据马德里标准(1953)分类为:结核麻风病(TT),边界线圈(BL),和Lepromatous Leprosy(LL)。对于所有参与者,完全血统计数(CBC),使用ELISA和单核细胞阳性的血清CD163α,使用流量的CD163进行。细胞测量术。结果:麻风病患者的WBC和血小板计数明显低(P <0.001),SCD163(P = 0.025)和MCD163(P = 0.042),其最高的LL后跟BL,然后TT患者(P <0.001) 。麻风病患者MCD163和SCD163水平之间存在显着的正相关(R = 0.896,P <0.001)。 ROC分析显示血清SCD163和MCD163阳性单核细胞在检测(P <0.001)中的显着作用(P <0.001),分别键入(P = 0.002和P <0.001)。结论:SCD163和MCD163阳性单核细胞均可在麻风病发病机制中具有积极作用。它们可能是麻风性检测和打字的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号